RxSight Inc announced educational opportunities and product updates at the American Academy of Ophthalmology's 127th Annual Meeting in San Francisco, California.
RxSight Inc today announced educational opportunities and product updates at the American Academy of Ophthalmology (AAO) Annual Meeting San Francisco.
Accoring to a news release, these include 3 scientific poster presentations (PO005, PO457, PO050) and 15 booth presentations.
At these events, leading U.S.-based ophthalmologists are slated to discuss diverse topics, including maximizing clinical results using the Light Adjustable Lens (LAL) across a broad range of patient profiles, integration of the adjustable lens workflow, and real-life case studies showing the impact of high-quality, customized LAL vision.
Steven Slade, MD, of Houston-based Slade & Baker Vision provided a report on clinical results using the LAL+, a new addition to the LAL family that will become available in the first quarter of 2024.
According to the company, the LAL+ has a built-in optical feature that is
designed to further extend the depth of focus before light treatments, while preserving the high-quality vision of the LAL already familiar to customers and patients.
RxSight’s reconfigured Light Delivery Device (LDD) will also be on display during AAO. While providing the same functionality and outcomes as the standard LDD, this compact model has a smaller footprint to address global practice space constraints.